Name: UMIN ID:
Unique ID issued by UMIN | UMIN000015727 |
---|---|
Receipt number | R000018010 |
Scientific Title | Randomized, controlled trial of the clinical effect of selecrive SGLT2 blocker, ipragliflozin, and DPP-4 blocker in type 2 diabetic patients with NAFLD/NASH.- multicenter study - |
Date of disclosure of the study information | 2014/11/24 |
Last modified on | 2020/01/12 15:28:22 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/11/20 16:40:23 | ||
2 | Update | 2015/03/10 11:28:11 | Target sample size |
|
3 | Update | 2015/03/10 11:32:25 | Organization Organization Category of Funding Organization |
|
4 | Update | 2016/06/06 15:15:04 | UMIN ID2 |
|
5 | Update | 2016/06/06 15:18:33 | Last name of lead principal investigator Last name of contact person Last name of contact person Name of primary person or sponsor Institute Organization Organization |
|
6 | Update | 2017/05/23 12:14:45 | Recruitment status Last follow-up date |
|
7 | Update | 2017/11/22 21:18:29 | Email Email1 |
|
8 | Update | 2017/11/22 21:20:06 | Recruitment status |
|
9 | Update | 2019/11/27 22:45:18 | Randomization unit |
|
10 | Update | 2019/11/27 22:51:12 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
11 | Update | 2020/01/12 15:21:00 | Number of participants that the trial has enrolled Results Delayed Results Delay Reason Results Delay Reason |
|
12 | Update | 2020/01/12 15:28:22 | Recruitment status Date of IRB Last follow-up date Date trial data considered complete Other related information Other related information |